Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/19/25 16:55 | 11/17/25 | ATRA | Health | BioPrd | Biological Products, (No Diag | Nguyen Anhco | CA | DO | P,CEO | 5 | S | -137 | 9.68 | 0 | -14 | 77 | D | |||||||||||||||
11/19/25 16:55 | 11/17/25 | ATRA | Health | BioPrd | Biological Products, (No Diag | Grant-Huerta Yanina | CA | O | Chief Ac | 3 | S | -60 | 10.26 | 0 | -6 | 37 | D | |||||||||||||||
3/5/25 17:17 | 3/3/25 | ATRA | Health | BioPrd | Biological Products, (No Diag | Hyllengren Eric J | CA | O | EVP,CFO, | 2 | S | -24 | 9.22 | 0 | -3 | 56 | D | |||||||||||||||
3/5/25 17:16 | 3/3/25 | ATRA | Health | BioPrd | Biological Products, (No Diag | Henrich Jill | CA | O | EVP,Chie | 2 | S | -19 | 9.04 | 0 | -2 | 19 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |